More than 300 cases of rare blood clot events worldwide: EMA
There were 287 occurrences with the AstraZeneca vaccine, eight with Johnson & Johnson's shot, 25 for Pfizer and five for Moderna
The headquarters of the European Medicines Agency (EMA), is seen in London, Britain, 25 April, 2017/ Reuters
The European Union's drug regulator said on Tuesday there had been more than 300 cases worldwide of rare blood clotting incidents combined with low platelet counts after use of Covid-19 vaccines.
There were 287 occurrences with the AstraZeneca vaccine, eight with Johnson & Johnson's shot, 25 for Pfizer and five for Moderna, said Peter Arlett, Head of Data Analytics at the European Medicines Agency (EMA).
Keep updated, follow The Business Standard's Google news channel
